NMS – Real vaqt narxi. Valyuta: USD
9.33
-0.85 (-8.35%)
Yopilishda: Mar 27, 2026, 4:00 PM EDT
9.43
+0.10 (1.07%)
Bozordan keyin: Mar 27, 2026, 7:49 PM EDT
4D Molecular Therapeutics, Inc., kechki bosqichdagi biotexnologiya kompaniyasi, Niderlandiya va Qo'shma Shtatlarda o'zining patentlangan Therapeutic Vector Evolution platformasi asosida adenoga assotsiatsiyalangan virus vektorlarini ishlab chiqish bilan shug'ullanadi. Kompaniyaning asosiy mahsulot nomzodi 4D-150 bo'lib, u ko'z ichiga in'ektsiya orqali retinadan anti-VEGF ning ko'p yillik barqaror ishlab chiqarishini ta'minlash orqali retinaning qon tomir kasalliklarini davolash uchun, shuningdek, nam yoshga bog'liq makula degeneratsiyasi va diabetik makula shishini davolash uchun mo'ljallangan. Kompaniya, shuningdek, kistoz fibrozni davolash uchun ilk bosqichda o'rganilayotgan 4D-710; geografik atrofiyani davolash uchun preklinik bosqichda bo'lgan 4D-175; va alfa-1 antitripsin etishmovchiligi o'pka kasalligini davolash uchun preklinik bosqichda bo'lgan 4D-725ni ishlab chiqmoqda. 4D Molecular Therapeutics, Inc. Otsuka Pharmaceutical Co., Ltd. bilan hamkorlik va litsenziyalash shartnomalariga ega. Kompaniya 2013-yilda tashkil etilgan va Kaliforniyaning Emeryville shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. An Song Ph.D. | Chief Translational Medicine Advisor |
| Dr. David H. Kirn M.D. | Co-Founder, President, CEO & Director |
| Dr. Fariborz Kamal Ph.D. | Chief Technical Advisor |
| Dr. John F. Milligan Ph.D. | Executive Chairman |
| Dr. Katy Barglow Ph.D. | Chief Technical Officer |
| Dr. Scott P. Bizily J.D., Ph.D. | Chief Legal Officer & Corporate Secretary |
| Julian Pei | Head of Investor Relations & Corporate Finance |
| Mr. Ashoo Gupta | Principal Accounting Officer & Principal Financial Officer |
| Mr. Kristian Humer M.B.A. | CFO & Principal Financial Officer |
| Ms. Theresa Janke | Co-Founder & Chief of Staff |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-03-18 | 8-K | fdmt-20260318.htm |
| 2026-01-26 | 8-K | fdmt-20260122.htm |
| 2026-01-07 | 8-K | fdmt-20251231.htm |
| 2025-12-10 | 8-K | fdmt-20251210.htm |
| 2025-11-17 | 8-K | d14139d8k.htm |
| 2025-11-10 | 10-Q | fdmt-20250930.htm |
| 2025-11-07 | 8-K | d89818d8k.htm |
| 2025-10-31 | 8-K | d41653d8k.htm |
| 2025-10-02 | 8-K | fdmt-20250930.htm |
| 2025-08-11 | 8-K | fdmt-20250811.htm |